A short list of molecules your body already speaks the language of — used, with lab work, to help you recover faster, sleep deeper, hold lean muscle, and feel more like yourself.
Think of peptides as messages your body already knows how to read — short chains of amino acids that tell specific cells to do specific things: repair this tissue, release a pulse of growth hormone, quiet that inflammation. Used precisely, they nudge a system that's drifted back toward the way it used to run.
What we reach for depends on what you're after. Recovery and tissue repair (BPC-157, TB-500). Sleep, lean mass, and the growth-hormone axis (Sermorelin, Ipamorelin, CJC-1295, Tesamorelin). Sexual health and desire (PT-141). Most are a small subcutaneous injection you give yourself at home — quick, almost painless. A few are intranasal.
An honest note up front: most peptides are not FDA-approved as finished drug products and are prescribed off-label — used for an indication, dose, or route not specifically FDA-approved. Off-label prescribing is legal and common in medicine, and we disclose it in writing at consent so you know exactly what you're agreeing to.
Your protocol — which peptide, how much, for how long — is built around your goals, your history, and your labs. We re-check those labs on a schedule. If something needs to change, we change it.
Who it helps.
Changes are quiet at first, then unmistakable — better sleep, faster recovery, a body that holds the work you're putting in.
What are you actually trying to fix? Sleep, recovery, body composition, intimacy. The peptide is picked for that goal — not pulled off a shelf.
Prescribed by your provider, compounded by a licensed pharmacy, and dosed for your physiology. No mystery vials, no internet workarounds.
Peptides sit inside your wider plan — labs at intervals, conversations about how you actually feel. If something needs to shift, we shift it.
Peptides reward patience — the early signal is usually sleep and recovery, with the slower tissue and body-composition work showing up between weeks 8 and 24. Here is the arc.
Hormone, metabolic, and (where indicated) IGF-1 baseline drawn. Your clinician selects the peptide — or stack — matched to the goal you actually walked in with.
Sub-Q injection technique taught in clinic. Sleep depth and recovery quality often shift first. Your care team is one message away if anything feels off.
Labs repeated against baseline. Dose, frequency, or protocol adjusted to your real numbers and response — not the protocol everyone else is on.
Full lab redraw against baseline. Exit criteria are reviewed honestly — cycle off, continue, switch protocols, or add another peptide to layer the goal forward.
Most peptide work happens in combinations chosen because the molecules support each other. These are the protocols we end up writing most often. Every one is dosed to your labs and your goals, never off a menu.
Studied for: tendon and ligament repair, gut-lining support, soft-tissue healing.
Often chosen by: athletes managing chronic injury, post-surgical patients, anyone with stubborn tissue concerns.
Both peptides are currently before the FDA Pharmacy Compounding Advisory Committee (July 2026); we source through partner 503A pharmacies and disclose status fully at consult.
Studied for: skin quality, scalp and hair support, wound and tissue repair at the surface.
Often chosen by: aesthetic patients pairing with injectables or laser work, hair-restoration adjuncts.
Same FDA-review note as the Wolverine Stack on BPC-157 / TB-500. GHK-Cu (copper peptide) has decades of cosmetic and wound-healing literature behind it.
Studied for: deeper sleep architecture, recovery between workouts, body composition over months.
Often chosen by: patients in their 40s and beyond noticing they don't bounce back the way they used to.
Sermorelin has a long FDA-approved history. Which combination is right depends on your IGF-1 baseline and goals — chosen at consult, not from a menu.
Studied for: mitochondrial function, telomere maintenance, cellular energy, biological-age markers.
Often chosen by: patients with focused interest in longevity protocols and willingness to track biomarkers over time.
Evidence base is genuinely emerging — some animal, some early human, some mechanistic. We discuss what's known and what isn't before adding any of these to your chart.
Studied for: arousal response, libido support, sexual function in both women and men.
Often chosen by: patients whose sexual concerns aren't fully addressed by hormone optimization alone.
Vyleesi is the FDA-approved bremelanotide. Compounded variants give us dosing flexibility plus an optional troche combining Tadalafil + PT-141 + Oxytocin when indicated.
We don't run protocols off a price sheet. Every stack starts with a panel and ends with a re-test — the stack that works for your sister probably isn't the one that works for you.
Compounded medical weight loss runs on its own protocol — provider visits, labs at 3 and 6 months, InBody body-composition tracking, MIC injections, and medication dispensed through our compounding partners. Built to be measured, not guessed.
Beyond the common stacks, we work with a wider menu when the clinical picture asks for it. Each one is a real conversation at consult — the evidence as it stands, what it could do for you specifically, what the regulatory pathway actually is.
Selank · Semax · DSIP (Delta Sleep-Inducing Peptide)
Thymosin Alpha 1 · Thymosin Beta 4 · LL-37
Kisspeptin-10 · Gonadorelin (injectable or troche)
5-Amino 1MQ · Cagrilintide
Fox04-DRI
Melanotan II (cosmetic tanning peptide; case-by-case use)
Anything on this menu is on the table at consult. We'll talk through whether it's right for you, what the evidence actually shows, and what the regulatory pathway is — before anything is prescribed.
Peptides are a category people read a lot about online — and most of what's out there is half-right. The honest version.
Most of the peptides we use are not FDA-approved as finished drug products — they're prescribed off-label and compounded by a licensed pharmacy. Off-label prescribing is legal and routine in medicine; we disclose it in writing at consent, with the evidence base for each one.
Internet "research peptides" are unregulated, often mislabeled, and not for human use — full stop. What we prescribe comes from a US-licensed compounding pharmacy, with a real prescription, a real dose calculated for you, and a clinician monitoring your response.
Yes — baseline lab work before we dose, then a re-check at roughly 8 to 12 weeks depending on the protocol. Peptides sit inside your wider picture (hormones, metabolic markers, sometimes IGF-1), so we want a real before-and-after, not a guess.
It depends on the peptide and the goal. Sleep and recovery shifts tend to show up in the first 2 to 6 weeks. Body composition and the slower tissue work take longer — often 8 to 12 weeks before the change is clearly yours and not just a good week.
Most are a small subcutaneous injection — a very fine needle into the fat just under the skin, similar to insulin. Patients are usually surprised by how little they feel. A few peptides (like PT-141) are intranasal instead.
No. Some protocols are cycled — eight to twelve weeks on, a stretch off — and some are run continuously while we watch labs and how you feel. We'll talk about exit criteria at the start, not as an afterthought.
A separate conversation, prescribed only when it fits — and only after a frank one about what we know, what we don’t, and what we’ll watch.
Rapamycin (sirolimus) is an mTOR inhibitor — FDA-approved decades ago as an immunosuppressant for solid-organ transplant patients. The longevity interest is something else entirely: low, pulsed dosing — typically 5–10 mg once weekly with periodic breaks — used for an indication the FDA has not approved.
The mechanism that drew the attention: intermittent mTOR inhibition appears to upregulate autophagy — the cellular process by which the body clears out damaged proteins and organelles. In animal models, particularly mice, that has translated into measurable lifespan extension across multiple labs. In humans, the longevity evidence is still emerging — we say so up front, in writing, at consent.
This is not a peptide. It is a small-molecule prescription drug used off-label for an investigational indication, and we treat it that way: cautiously, with screening, and with the door open to stop.
Patient selection comes first. Before a single dose, we screen immune status, fasting glucose and HbA1c, full lipid panel, and a wider metabolic picture. Rapamycin isn’t right for everyone, and there are histories — active infection, certain metabolic profiles, pregnancy or attempts thereof, planned surgery — where we’ll decline or defer.
Once started, the side-effect signals we monitor are specific: mouth sores, shifts in fasting glucose, changes in LDL and triglycerides, and any sign of immune modulation showing up as slower healing or a cold that lingers. Quarterly labs are built into the protocol — not optional — alongside a candid conversation about whether to continue, pause, or stop.
Disclosure: Rapamycin is not FDA-approved for longevity, healthspan, or anti-aging indications. Its use in this context is off-label and investigational. Long-term safety data in healthy adults taking pulsed low-dose rapamycin is limited. We disclose all of this in writing at consent and reserve the right to decline if the risk-benefit isn’t there for you.
We start with your labs — so the peptide we reach for is the one your body is actually asking for, not the one trending this quarter.
Plus: how we’d use a summer with the schedule on your side. One page, refreshed each month.
Read this month →